Serotoninergic Block in the Ventromedial Nucleus of Hypothalamus Improves Food Intake in Anorectic Tumor Bearing Rats
In animal models, cancer associated anorexia has been extensively investigated. We recently showed that cancer anorexia is primarily a centrally mediated phenomenon, in which the ventromedial nucleus of hypothalamus (VMH) plays a significant role (Laviano et al., 1995). Under normal conditions, VMH is known to significantly participates in mediating satiety, primarily via the neurotransmitter serotonin (Leibowitz, 1990). Serotonin has also been postulated to mediate cancer anorexia (Rossi Fanelli and Cangiano, 1991), and the previously reported involvement of VMH, a predominantly serotoninergic nucleus, in the development of reduced food intake during tumor growth is in agreement with this supposition (Laviano et al., 1995).
KeywordsFood Intake Eating Disorder Reduce Food Intake Free Amino Acid Content Serotonin Antagonist
Unable to display preview. Download preview PDF.
- Landel AM, Lo CC, Meguid MM, et al., 1987, Effect of methylcholanthrene-induced sarcoma and its removal on rat plasma and intracellular free amino acid content. Surg. Res. Commun. 1:273.Google Scholar
- Laviano A, Meguid MM, Gleason JR, et al., 1995, Hypothalamic sites of cancer anorexia in the tumor bearing rat. Cancer Res., (submitted)Google Scholar
- Meguid MM, Muscaritoli M, Beverly JL, et al., 1992, The early cancer anorexia paradigm: changes in plasma free tryptophan and feeding indexes. JPEN 16 (suppl. 6):56S.Google Scholar
- Rossi Fanelli F, Cangiano C., 1991, Increased availability of tryptophan in brain as a common pathogenic mechanism for anorexia associated with different diseases. Nutrition 7:364.Google Scholar